Interactions of the PDZ-protein MAGI-1 with adenovirus E4-ORF1 and high-risk papillomavirus E6 oncoproteins

被引:238
作者
Glaunsinger, BA
Lee, SS
Thomas, M
Banks, L
Javier, R [1 ]
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Int Ctr Genet Engn & Biotechnol, I-34012 Trieste, Italy
关键词
adenovirus E4-ORF1; MAGI-1; papillomavirus; E6; PDZ;
D O I
10.1038/sj.onc.1203906
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The oncoproteins of small DNA tumor viruses promote tumorigenesis by complexing with cellular factors intimately involved in the control of cell proliferation. The major oncogenic determinants for human adenovirus type 9 (Ad9) and high-risk human papillomaviruses (HPV) are the E4-ORF1 and E6 proteins, respectively. These seemingly unrelated viral oncoproteins are similar in that their transforming activities in cells depend, in part, on a carboxyl-terminal PDZ domain-binding motif which mediates interactions with the cellular PDZ-protein DLG. Here we demonstrated that both Ad9 E4-ORF1 and high-risk HPV E6 proteins also bind to the DLG-related PDZ-protein MAGI-1. These interactions resulted in MAGI-1 being aberrantly sequestered in the cytoplasm by the Ad9 E4-ORF1 protein or being targeted for degradation by high-risk HPV E6 proteins. Transformation-defective mutant viral proteins, however, were deficient for these activities. Our findings indicate that MAGI-1 is a member of a select group of cellular PDZ proteins targeted by both adenovirus E4-ORF1 and high-risk HPV E6 proteins and, in addition, suggest that the tumorigenic potentials of these viral oncoproteins depend, in part, on an ability to inhibit the function of MAGI-1 in cells.
引用
收藏
页码:5270 / 5280
页数:11
相关论文
共 37 条
[1]   PREVALENCE OF HUMAN PAPILLOMAVIRUS IN CERVICAL-CANCER - A WORLDWIDE PERSPECTIVE [J].
BOSCH, FX ;
MANOS, MM ;
MUNOZ, N ;
SHERMAN, M ;
JANSEN, AM ;
PETO, J ;
SCHIFFMAN, MH ;
MORENO, V ;
KURMAN, R ;
SHAH, KV ;
ALIHONOU, E ;
BAYO, S ;
MOKHTAR, HC ;
CHICAREON, S ;
DAUDT, A ;
DELOSRIOS, E ;
GHADIRIAN, P ;
KITINYA, JN ;
KOULIBALY, M ;
NGELANGEL, C ;
TINTORE, LMP ;
RIOSDALENZ, JL ;
SARJADI ;
SCHNEIDER, A ;
TAFUR, L ;
TEYSSIE, AR ;
ROLON, PA ;
TORROELLA, M ;
TAPIA, AV ;
WABINGA, HR ;
ZATONSKI, W ;
SYLLA, B ;
VIZCAINO, P ;
MAGNIN, D ;
KALDOR, J ;
GREER, C ;
WHEELER, C .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1995, 87 (11) :796-802
[2]  
BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
[3]   PDZ proteins organize synaptic signaling pathways [J].
Craven, SE ;
Bredt, DS .
CELL, 1998, 93 (04) :495-498
[4]   MAGI-1, a membrane-associated guanylate kinase with a unique arrangement of protein-protein interaction domains [J].
Dobrosotskaya, I ;
Guy, RK ;
James, GL .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (50) :31589-31597
[5]   PDZ domains: fundamental building blocks in the organization of protein complexes at the plasma membrane [J].
Fanning, AS ;
Anderson, JM .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 103 (06) :767-772
[6]   ANALYSIS OF TYPE-5 ADENOVIRUS TRANSFORMATION WITH A CLONED RAT EMBRYO CELL-LINE (CREF) [J].
FISHER, PB ;
BABISS, LE ;
WEINSTEIN, IB ;
GINSBERG, HS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (11) :3527-3531
[7]   Oncogenic human papillomavirus E6 proteins target the discs large tumour suppressor for proteasome-mediated degradation [J].
Gardiol, D ;
Kühne, C ;
Glaunsinger, B ;
Lee, SS ;
Javier, R ;
Banks, L .
ONCOGENE, 1999, 18 (40) :5487-5496
[8]   SV40-TRANSFORMED SIMIAN CELLS SUPPORT THE REPLICATION OF EARLY SV40 MUTANTS [J].
GLUZMAN, Y .
CELL, 1981, 23 (01) :175-182
[9]   The junction-associated protein, zonula occludens-1, localizes to the nucleus before the maturation and during the remodeling of cell-cell contacts [J].
Gottardi, CJ ;
Arpin, M ;
Fanning, AS ;
Louvard, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (20) :10779-10784
[10]  
Harlow E, 1988, ANTIBODIES LABORATOR, P359